Improving therapy for patients with epidermal growth factor receptor-mutant lung cancer

被引：2

作者：

Arbour, Kathryn C. ^{[1
]}

Riely, Gregory J. ^{[1
]}

机构：

[1] Weill Cornell Med Coll, Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY USA

来源：

CANCER | 2018年 / 124卷 / 11期

关键词：

ACQUIRED-RESISTANCE; INITIAL TREATMENT; OSIMERTINIB; MUTATIONS; ERLOTINIB; BEVACIZUMAB; INHIBITION; GEFITINIB; EMERGENCE; AZD9291;

D O I：

10.1002/cncr.31289

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：2272 / 2275

页数：4

共 23 条

[1] TATTON Ph Ib Expansion Cohort: Osimertinib plus Savolitinib for Pts with EGFR-Mutant MET-Amplified NSCLC after Progression on Prior EGFR-TKI [J].

Ahn, M. ;

Han, J. ;

Sequist, L. ;

Cho, B. C. ;

Lee, J. S. ;

Kim, S. ;

Su, W. ;

Tsai, C. ;

Yang, J. C. ;

Yu, H. ;

Horn, L. ;

Lee, K. ;

Haddad, V. ;

Frigault, M. ;

Ahmed, G. ;

Yang, L. ;

Ghiorghiu, D. ;

Oxnard, G. .

JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) :S1768-S1768

[2] Osimertinib combined with durvalumab in EGFR-mutant non-small cell lung cancer: Results from the TATTON phase Ib trial [J].

Ahn, M. -J. ;

Yang, J. ;

Yu, H. ;

Saka, H. ;

Ramalingam, S. ;

Goto, K. ;

Kim, S. -W. ;

Yang, L. ;

Walding, A. ;

Oxnard, G. R. .

JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (04) :S115-S115

[3] Twice weekly pulse and daily continuous-dose erlotinib as initial treatment for patients with epidermal growth factor receptor-mutant lung cancers and brain metastases [J].

Arbour, Kathryn C. ;

Kris, Mark G. ;

Riely, Gregory J. ;

Ni, Ai ;

Beal, Kathryn ;

Daras, Mariza ;

Hayes, Sara A. ;

Young, Robert J. ;

Rodriguez, Christopher R. ;

Ahn, Linda ;

Pao, William ;

Yu, Helena A. .

CANCER, 2018, 124 (01) :105-109

[4] MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib [J].

Bean, James ;

Brennan, Cameron ;

Shih, Jin-Yuan ;

Riely, Gregory ;

Viale, Agnes ;

Wang, Lu ;

Chitale, Dhananjay ;

Motoi, Noriko ;

Szoke, Janos ;

Broderick, Stephen ;

Balak, Marissa ;

Chang, Wen-Cheng ;

Yu, Chong-Jen ;

Gazdar, Adi ;

Pass, Harvey ;

Rusch, Valerie ;

Gerald, William ;

Huang, Shiu-Feng ;

Yang, Pan-Chyr ;

Miller, Vincent ;

Ladany, Marc ;

Yang, Chih-Hsin ;

Pao, William .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (52) :20932-20937

[5] L718Q Mutation as New Mechanism of Acquired Resistance to AZD9291 in EGFR-Mutated NSCLC [J].

Bersanelli, Melissa ;

Minari, Roberta ;

Bordi, Paola ;

Gnetti, Letizia ;

Bozzetti, Cecilia ;

Squadrilli, Anna ;

Lagrasta, Costanza Anna Maria ;

Bottarelli, Lorena ;

Osipova, Ganna ;

Capelletto, Enrica ;

Mor, Marco ;

Tiseo, Marcello .

JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (10) :E121-+

[6] Optimization of Dosing for EGFR-Mutant Non-Small Cell Lung Cancer with Evolutionary Cancer Modeling [J].

Chmielecki, Juliann ;

Foo, Jasmine ;

Oxnard, Geoffrey R. ;

Hutchinson, Katherine ;

Ohashi, Kadoaki ;

Somwar, Romel ;

Wang, Lu ;

Amato, Katherine R. ;

Arcila, Maria ;

Sos, Martin L. ;

Socci, Nicholas D. ;

Viale, Agnes ;

de Stanchina, Elisa ;

Ginsberg, Michelle S. ;

Thomas, Roman K. ;

Kris, Mark G. ;

Inoue, Akira ;

Ladanyi, Marc ;

Miller, Vincent A. ;

Michor, Franziska ;

Pao, William .

SCIENCE TRANSLATIONAL MEDICINE, 2011, 3 (90)

[7]

ClinicalTrials. gov, 2018, PHAS 1 2 TRIAL TRAM

[8] MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling [J].

Engelman, Jeffrey A. ;

Zejnullahu, Kreshnik ;

Mitsudomi, Tetsuya ;

Song, Youngchul ;

Hyland, Courtney ;

Park, Joon Oh ;

Lindeman, Neal ;

Gale, Christopher-Michael ;

Zhao, Xiaojun ;

Christensen, James ;

Kosaka, Takayuki ;

Holmes, Alison J. ;

Rogers, Andrew M. ;

Cappuzzo, Federico ;

Mok, Tony ;

Lee, Charles ;

Johnson, Bruce E. ;

Cantley, Lewis C. ;

Janne, Pasi A. .

SCIENCE, 2007, 316 (5827) :1039-1043

[9] Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition [J].

Hata, Aaron N. ;

Niederst, Matthew J. ;

Archibald, Hannah L. ;

Gomez-Caraballo, Maria ;

Siddiqui, Faria M. ;

Mulvey, Hillary E. ;

Maruvka, Yosef E. ;

Ji, Fei ;

Bhang, Hyo-eun C. ;

Radhakrishna, Viveksagar Krishnamurthy ;

Siravegna, Giulia ;

Hu, Haichuan ;

Raoof, Sana ;

Lockerman, Elizabeth ;

Kalsy, Anuj ;

Lee, Dana ;

Keating, Celina L. ;

Ruddy, David A. ;

Damon, Leah J. ;

Crystal, Adam S. ;

Costa, Carlotta ;

Piotrowska, Zofia ;

Bardelli, Alberto ;

Iafrate, Anthony J. ;

Sadreyev, Ruslan I. ;

Stegmeier, Frank ;

Getz, Gad ;

Sequist, Lecia V. ;

Faber, Anthony C. ;

Engelman, Jeffrey A. .

NATURE MEDICINE, 2016, 22 (03) :262-269

[10] Checkpoint Inhibitors in Metastatic EGFR-Mutated Non-Small Cell Lung Cancer A Meta-Analysis [J].

Lee, Chee Khoon ;

Man, Johnathan ;

Lord, Sally ;

Links, Matthew ;

Gebski, Val ;

Mok, Tony ;

Yang, James Chih-Hsin .

JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (02) :403-407

← 1 2 3 →